Latest filing published 04 Apr 2025 for REGENXBIO Inc., €42k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Olivier Danos: trading record in brief
This profile gathers the share dealings of Olivier Danos in REGENXBIO Inc., where the filings describe the role as senior executive. The record holds 28 filings, for trades running from 8 October 2018 to 1 February 2025.
On the market, this insider has only sold: 6 sales, €1.2M in total. Other entries cover 18 share grants and 4 option exercises.
The record was last updated on 4 April 2025 with a share grant (€42k) in REGENXBIO Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Olivier Danos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,452 shares@ US$8.0717.7% of flowCommon StockSEC:0001562180-25-003008:0
- 12,630 shares@ US$7.7339.5% of flowCommon StockSEC:0001562180-25-000189:0
- 1,363 shares@ US$9.9455.3% of flowCommon StockSEC:0001562180-24-006013:0
- 728 shares@ US$20.9956.1% of flowCommon StockSEC:0001562180-24-000249:0
- 2,058 shares@ US$22.6818.3% of flowCommon StockSEC:0001562180-23-000220:0
- 555 shares@ US$33.02257.4% of flowCommon StockSEC:0001562180-22-000156:0
6 of 6 declarations
